Skip to content
Aurexus

Legal

Accessibility Statement

Accessibility Statement

Effective 30 July 2026 · Last updated 30 July 2026

Introduction

Aurexus Group Ltd ("Aurexus", "we", "us" or "our") is committed to ensuring digital accessibility for people with disabilities. We believe intelligent transformation must include everyone — technology should strengthen participation, not create barriers.

This Accessibility Statement applies to https://www.aurexus-group.com and describes our approach, current conformance status and feedback mechanisms. Platform-specific statements may apply to BioAegix, NPTTE PharmaNG and BeatIQ where deployed in operational environments.

Our Commitment

We aim to conform to the Web Content Accessibility Guidelines (WCAG) 2.2 at Level AA, in line with recognised best practice and the Public Sector Bodies (Websites and Mobile Applications) Accessibility Regulations 2018 principles, which we adopt voluntarily as a standard for inclusive design.

Accessibility is integrated into our engineering approach — not treated as an afterthought. This aligns with our principle that people come before platforms.

Measures We Take

To support accessibility, we:

  • Design with semantic HTML, logical heading structure and meaningful link text
  • Provide text alternatives for non-text content where appropriate
  • Ensure sufficient colour contrast between text and backgrounds
  • Support keyboard navigation and visible focus indicators
  • Include a skip-to-content link on our corporate website
  • Use responsive layouts that adapt to different screen sizes and zoom levels
  • Select fonts and spacing that support readability
  • Test with automated accessibility tools and manual checks during development
  • Consider accessibility in third-party component and service selection

Current Status

Corporate website (aurexus-group.com)

We are actively working towards WCAG 2.2 Level AA conformance. As an early-stage company building and refining our digital presence, some areas may not yet fully meet all success criteria.

Known areas we are improving include:

  • Comprehensive alternative text coverage across all imagery
  • Full keyboard operability for all interactive components
  • Enhanced ARIA labelling for dynamic content
  • Document accessibility for downloadable materials
  • Captions and transcripts for video content when published

We conduct periodic reviews and prioritise remediation based on user impact.

Product platforms

BioAegix, NPTTE PharmaNG and BeatIQ are designed with accessibility considerations appropriate to their user contexts. Client deployments may include additional accessibility requirements defined in contractual agreements. Platform-specific conformance statements will be published as products mature.

Assistive Technology Compatibility

We aim to support common assistive technologies, including:

  • Screen readers (such as NVDA, JAWS and VoiceOver)
  • Screen magnification software
  • Speech recognition tools
  • Keyboard-only navigation

Compatibility may vary by browser, operating system and assistive technology version. We test against current versions of major browsers including Chrome, Firefox, Safari and Edge.

Third-Party Content

Some content on our website may be provided by third parties (embedded maps, videos, social media widgets). We cannot guarantee the accessibility of third-party content but request accessible alternatives where practicable.

Feedback and Contact

We welcome feedback on the accessibility of our website and services. If you encounter a barrier or need information in an alternative format, please contact us:

Email: admin@bioaegix.com
Subject line: Accessibility Feedback
Post: Accessibility, Aurexus Group Ltd, Unit A, 82 James Carter Road, Mildenhall, Bury St. Edmunds, Suffolk, England, IP28 7DE

Please include:

  • The page URL or feature affected
  • A description of the problem
  • The assistive technology and browser you are using (if applicable)
  • Your preferred contact method for follow-up

We aim to acknowledge accessibility feedback within five business days and provide a substantive response within 20 business days.

Enforcement Procedure

If you are not satisfied with our response, you may contact the Equality Advisory Support Service (EASS):

Website: https://www.equalityadvisoryservice.com
Telephone: 0808 800 0082

The Equality and Human Rights Commission (EHRC) is responsible for enforcing the Equality Act 2010, which requires service providers to make reasonable adjustments for disabled people.

Continuous Improvement

Accessibility is an ongoing commitment. We will:

  • Include accessibility requirements in design and development standards
  • Train personnel on inclusive design principles
  • Reassess conformance following significant website changes
  • Update this statement as our conformance status improves

Preparation of This Statement

This statement was prepared on 30 July 2026. It was last reviewed on 30 July 2026.

Governing law: England and Wales